Varenicline Tartrate + Placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tobacco Use Cessation
Conditions
Tobacco Use Cessation
Trial Timeline
Aug 1, 2008 → Jul 1, 2009
NCT ID
NCT00717093About Varenicline Tartrate + Placebo
Varenicline Tartrate + Placebo is a approved stage product being developed by Pfizer for Tobacco Use Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00717093. Target conditions include Tobacco Use Cessation.
What happened to similar drugs?
6 of 9 similar drugs in Tobacco Use Cessation were approved
Approved (6) Terminated (3) Active (2)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01370356 | Approved | Completed |
| NCT00717093 | Approved | Completed |
| NCT00371813 | Phase 3 | Completed |
Competing Products
20 competing products in Tobacco Use Cessation